PL1656139T3 - Arylodikarboksyamidy - Google Patents

Arylodikarboksyamidy

Info

Publication number
PL1656139T3
PL1656139T3 PL04742005T PL04742005T PL1656139T3 PL 1656139 T3 PL1656139 T3 PL 1656139T3 PL 04742005 T PL04742005 T PL 04742005T PL 04742005 T PL04742005 T PL 04742005T PL 1656139 T3 PL1656139 T3 PL 1656139T3
Authority
PL
Poland
Prior art keywords
sub
sup
aryl
alkyl
carboxy
Prior art date
Application number
PL04742005T
Other languages
English (en)
Inventor
Russel J Thomas
Dominique Swinnen
Jean-François Pons
Agnès Bombrun
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Publication of PL1656139T3 publication Critical patent/PL1656139T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/28Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
    • C07C237/42Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
PL04742005T 2003-07-21 2004-07-20 Arylodikarboksyamidy PL1656139T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03102236 2003-07-21
US51782403P 2003-11-06 2003-11-06
EP04742005A EP1656139B1 (en) 2003-07-21 2004-07-20 Aryl dicarboxamides
PCT/EP2004/051558 WO2005011685A1 (en) 2003-07-21 2004-07-20 Aryl dicarboxamides

Publications (1)

Publication Number Publication Date
PL1656139T3 true PL1656139T3 (pl) 2012-03-30

Family

ID=34924079

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04742005T PL1656139T3 (pl) 2003-07-21 2004-07-20 Arylodikarboksyamidy

Country Status (12)

Country Link
US (1) US7365225B2 (pl)
EP (1) EP1656139B1 (pl)
JP (1) JP2006528157A (pl)
AT (1) ATE526964T1 (pl)
AU (1) AU2004260831A1 (pl)
CA (1) CA2529662A1 (pl)
DK (1) DK1656139T3 (pl)
ES (1) ES2375132T3 (pl)
PL (1) PL1656139T3 (pl)
PT (1) PT1656139E (pl)
SI (1) SI1656139T1 (pl)
WO (1) WO2005011685A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1654247B1 (en) * 2003-07-21 2010-01-20 Merck Serono SA Alkynyl aryl carboxamides
JP2008007405A (ja) * 2004-12-07 2008-01-17 Takeda Chem Ind Ltd カルボキサミド誘導体
JP2009501721A (ja) * 2005-07-12 2009-01-22 アカディア ファーマシューティカルズ インコーポレイテッド レチノイン酸受容体における活性を伴う化合物
ITRM20050390A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
JPWO2007043401A1 (ja) * 2005-10-07 2009-04-16 キッセイ薬品工業株式会社 含窒素複素環化合物およびそれを含有する医薬組成物
AR068193A1 (es) 2007-08-13 2009-11-11 Divergence Inc Composiciones y metodos para controlar nematodos
DE102007061764A1 (de) 2007-12-20 2009-06-25 Bayer Healthcare Ag Anellierte Cyanopyridine und ihre Verwendung
DE202011110963U1 (de) * 2010-11-05 2017-11-07 Senomyx, Inc. Verbindungen, die als Modulatoren von TRPM8 nützlich sind
MX2018004049A (es) 2015-10-01 2018-09-28 Senomyx Inc Compuestos utiles como moduladores de canal receptor 8 de potencial transitorio de melastatina (trpm8).
CO2018004165A2 (es) 2015-10-23 2018-09-20 Vifor Int Ag Inhibidores de ferroportina
JOP20180036A1 (ar) 2017-04-18 2019-01-30 Vifor Int Ag أملاح لمثبطات فروبورتين جديدة

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002544254A (ja) * 1999-05-17 2002-12-24 ノボ ノルディスク アクティーゼルスカブ グルカゴンアンタゴニスト/逆アゴニスト
HUP0301501A2 (hu) * 2000-06-23 2003-08-28 Novo Nordisk A/S Glükagon antaagonista/inverz agonista vegyületek, ezeket tartalmazó gyógyászati készítmények, valamint a vegyületek alkalmazása gyógyászati készítmények előállítására
US6972340B2 (en) * 2000-08-29 2005-12-06 Abbott Laboratories Selective protein tyrosine phosphatatase inhibitors
DE10044792A1 (de) * 2000-09-11 2002-04-04 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung
JP2004513935A (ja) * 2000-11-17 2004-05-13 ノボ ノルディスク アクティーゼルスカブ グルカゴンアンタゴニスト/逆アゴニスト
AU2002223501A1 (en) * 2000-11-17 2002-05-27 Agouron Pharmaceuticals, Inc. Glucagon antagonists/inverse agonists
US6878743B2 (en) 2001-09-18 2005-04-12 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
PT1470102E (pt) * 2002-01-29 2011-06-06 Merck Serono Sa Derivados metilenamida substituídos como moduladores de proteína-tirosina fosfatases (ptps)
EP1654247B1 (en) * 2003-07-21 2010-01-20 Merck Serono SA Alkynyl aryl carboxamides

Also Published As

Publication number Publication date
PT1656139E (pt) 2011-11-04
AU2004260831A1 (en) 2005-02-10
SI1656139T1 (sl) 2011-12-30
US7365225B2 (en) 2008-04-29
ATE526964T1 (de) 2011-10-15
JP2006528157A (ja) 2006-12-14
EP1656139A1 (en) 2006-05-17
ES2375132T3 (es) 2012-02-27
CA2529662A1 (en) 2005-02-10
EP1656139B1 (en) 2011-10-05
US20060189583A1 (en) 2006-08-24
WO2005011685A1 (en) 2005-02-10
DK1656139T3 (da) 2012-01-30

Similar Documents

Publication Publication Date Title
CA2411778A1 (en) Organic compounds
EA200870489A1 (ru) Пиперидинилзамещённые пирролидиноны в качестве ингибиторов 11-бета-гидроксистероид дегидрогеназы 1
SI1656139T1 (sl) Aril dikarboksamidi
EP1609798A4 (en) CONDENSED HETEROCYCLIC DERIVATIVE, MEDICAL COMPOSITION, AND MEDICAL USE THEREOF
UY26089A1 (es) Inhibidores de la sorbitol deshidrogenasa
MY129023A (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
PL1807072T3 (pl) Cykloalkilowe pochodne laktamów jako inhibitory 11-ß-HSD1
DK1213296T3 (da) Glucopyranosyloxpyrazolderivater, lægemidler indeholdende samme samt mellemprodukter til fremstilling heraf
WO2009068531A3 (en) Adamantyl o-glucuronide derivatives as inhibitors of dipeptidyl peptidase iv for the treatment of diabetes
WO2004037181A3 (en) Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
BR0317451A (pt) Composto, composição farmacêutica, e, uso de um composto
EP1829865A3 (en) O-Cyclopropyl-carboxanilides and their use as fungicides
TNSN08405A1 (en) Cyclohexylpyrazole - lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
EA200601660A1 (ru) Ингибирующие mtp арилпиперидины или пиперазины, замещенные 5-членными гетероциклами
WO2007127763A3 (en) Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
EA200870470A1 (ru) Ингибиторы 11-бета-гидроксистероид дегидрогеназы 1
IL176171A0 (en) N-aryl piperidine substituted biphenylcarboxamides
WO2008142859A1 (ja) 新規なスピロオキシインドール化合物及びこれを含有する医薬
TW200631951A (en) 1-Substituted-3-(β-D-glycopyranosyl)nitrogen-containing heterocyclic compound and a medical composition containing the same
NZ602099A (en) Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient
ATE455772T1 (de) Alkinylarylcarbonsäureamide
MY152172A (en) Therapeutic agent for diabetes
UA85405C2 (ru) Производные 1,1'-(1,2-этиндиил)бис-бензола как ингибиторы ртр-1в
NZ594244A (en) Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
AR033349A1 (es) Compuesto heterociclico y composicion farmaceutica, agente hipoglucemico, agente hipolipidemico, mejorador de la resistencia a la insulina, agente terapeutico para las complicaciones de origen diabetico y agente terapeutico para la diabetes que los comprenden